The Immunologic Effects of Dupilumab in the Treatment of Dermal Hypersensitivity Reaction
Clinical trial NCT06012448 · COMPLETED
Trial details
- NCT number
- NCT06012448
- Sponsor
- University of Michigan
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-02
- Primary completion
- 2025-01-07
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.